- Home
- VCEL vs XPRO Comparison
VCEL vs XPRO Comparison
Compare VCEL & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- XPRO
- Stock Information
- Founded
- VCEL 1989
- XPRO 1938
- Country
- VCEL United States
- XPRO United States
- Employees
- VCEL N/A
- XPRO N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- XPRO Oilfield Services/Equipment
- Sector
- VCEL Health Care
- XPRO Energy
- Exchange
- VCEL Nasdaq
- XPRO Nasdaq
- Market Cap
- VCEL 1.6B
- XPRO 1.5B
- IPO Year
- VCEL 1997
- XPRO 2013
- Fundamental
- Price
- VCEL $33.59
- XPRO $12.58
- Analyst Decision
- VCEL Strong Buy
- XPRO Buy
- Analyst Count
- VCEL 6
- XPRO 4
- Target Price
- VCEL $58.60
- XPRO $12.50
- AVG Volume (30 Days)
- VCEL 703.6K
- XPRO 1.2M
- Earning Date
- VCEL 11-06-2025
- XPRO 10-23-2025
- Dividend Yield
- VCEL N/A
- XPRO N/A
- EPS Growth
- VCEL 2045.40
- XPRO N/A
- EPS
- VCEL 0.13
- XPRO 0.61
- Revenue
- VCEL $249,119,000.00
- XPRO $1,673,283,000.00
- Revenue This Year
- VCEL $18.35
- XPRO N/A
- Revenue Next Year
- VCEL $22.26
- XPRO $3.69
- P/E Ratio
- VCEL $259.38
- XPRO $20.73
- Revenue Growth
- VCEL 16.13
- XPRO 2.67
- 52 Week Low
- VCEL $29.24
- XPRO $6.70
- 52 Week High
- VCEL $63.00
- XPRO $17.38
- Technical
- Relative Strength Index (RSI)
- VCEL 52.73
- XPRO 52.47
- Support Level
- VCEL $31.34
- XPRO $11.92
- Resistance Level
- VCEL $35.70
- XPRO $13.35
- Average True Range (ATR)
- VCEL 1.48
- XPRO 0.57
- MACD
- VCEL 0.46
- XPRO -0.07
- Stochastic Oscillator
- VCEL 71.12
- XPRO 48.57
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.